A Phase II Study of Bipolar Androgen-based Therapy for Men With Androgen Ablation Naive Recurrent Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 11 Jun 2018
At a glance
- Drugs Testosterone cipionate (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms BAT
- 31 Aug 2018 Biomarkers information updated
- 24 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Dec 2014 Planned End Date changed from 1 Jan 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov record.